BMV:IBB Holdings Information

BMV:IBB is an equity ETF with a total of 258 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 7.82%, Amgen at 7.70%, Gilead Sciences at 7.68%, Regeneron Pharmaceuticals at 6.50%, and Alnylam Pharmaceuticals at 4.77%.

Total Holdings

258

Top 10 Percentage

47.91%

Asset Class

Equity

ETF Category

Health Care

Assets

5.47B

PE Ratio

18.61

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	VRTX	Vertex Pharmaceuticals Incorporated	7.82%	904,815
2	AMGN	Amgen Inc.	7.70%	1,387,928
3	GILD	Gilead Sciences, Inc.	7.68%	3,633,472
4	REGN	Regeneron Pharmaceuticals, Inc.	6.50%	636,223
5	ALNY	Alnylam Pharmaceuticals, Inc.	4.77%	762,223
6	IQV	IQVIA Holdings Inc.	3.70%	1,048,520
7	MTD	Mettler-Toledo International Inc.	2.95%	126,501
8	ARGX	argenx SE	2.60%	235,341
9	INSM	Insmed Incorporated	2.11%	1,088,054
10	BIIB	Biogen Inc.	2.09%	894,300
11	NTRA	Natera, Inc.	2.05%	790,425
12	WAT	Waters Corporation	2.00%	363,057
13	ONC	BeOne Medicines Ltd.	1.88%	341,062
14	BNTX	BioNTech SE	1.86%	915,519
15	ILMN	Illumina, Inc.	1.85%	939,744
16	INCY	Incyte Corporation	1.67%	1,166,164
17	NBIX	Neurocrine Biosciences, Inc.	1.47%	583,666
18	UTHR	United Therapeutics Corporation	1.40%	268,922
19	BMRN	BioMarin Pharmaceutical Inc.	1.25%	1,155,864
20	MRNA	Moderna, Inc.	1.24%	2,093,903
21	MEDP	Medpace Holdings, Inc.	1.15%	142,560
22	EXEL	Exelixis, Inc.	1.10%	1,613,752
23	GMAB	Genmab A/S	1.02%	2,480,116
24	TECH	Bio-Techne Corporation	1.01%	947,598
25	CRL	Charles River Laboratories International, Inc.	0.96%	296,885

As of Jul 30, 2025

Showing 25 of 258

Subscribe to see the full list